Home  /  Resource Library  /  Efficacy and Safety of Ublituximab in Combination with Umbralisib (U2) in Patients with Chronic Lymphocytic Leukemia (CLL) By Treatment Status: A Sub Analysis of the Phase 3 Unity-CLL Study

Efficacy and Safety of Ublituximab in Combination with Umbralisib (U2) in Patients with Chronic Lymphocytic Leukemia (CLL) By Treatment Status: A Sub Analysis of the Phase 3 Unity-CLL Study

ASH 2021